LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6

Biochemical and Biophysical Research Communications

Volumn 478, Issue 3, 2016, Pages 1442-1448

  Wu, Chao ^a   Liu, Ye ^a   Gu, Xiangxiang ^a   Zhu, Tianhui ^a   Yang, Shuang ^a   Sun, Wei ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

FAT10ylation; LMO2; UBA6; USE1

Indexed keywords

LMO 2 PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME USE1; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE 6; UNCLASSIFIED DRUG; LIM PROTEIN; LMO2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBA6 PROTEIN, HUMAN; UBD PROTEIN, HUMAN; UBIQUITIN; USE1 PROTEIN, HUMAN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; EMBRYO; ENZYME DEGRADATION; EPITHELIUM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; WESTERN BLOTTING; CHEMISTRY; HEK293 CELL LINE; METABOLISM; PROTEIN SECONDARY STRUCTURE; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; CYTOPLASM; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; LIM DOMAIN PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS; UBIQUITIN; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITINS;

EID: 84993990196     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.08.143     Document Type: Article

References (27)

1. [1] Royer-Pokora, B., Loos, U., Ludwig, W.D., TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 6 (1991), 1887–1893.
2. [2] Yamada, Y., Pannell, R., Forster, A., Rabbitts, T.H., The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 320–324.
3. [3] Yamada, Y., Warren, A.J., Dobson, C., Forster, A., Pannell, R., Rabbitts, T.H., The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 3890–3895.
4. [4] Pike-Overzet, K., de Ridder, D., Weerkamp, F., Baert, M.R., Verstegen, M.M., et al. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy. Leukemia 21 (2007), 754–763.
5. [5] McCormack, M.P., Young, L.F., Vasudevan, S., de Graaf, C.A., Codrington, R., Rabbitts, T.H., Jane, S.M., Curtis, D.J., The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 327 (2010), 879–883.
6. [6] McCormack, M.P., Rabbitts, T.H., Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 350 (2004), 913–922.
7. [7] Zhu, T., Qin, G., Royer-Pokora, B., A novel post-transcriptional splicing form of the acute T cell leukemia proto-oncogene Lmo2. Sci. China C Life Sci. 44 (2001), 561–569.
8. [8] Wadman, I.A., Osada, H., Grutz, G.G., Agulnick, A.D., Westphal, H., Forster, A., Rabbitts, T.H., The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16 (1997), 3145–3157.
9. [9] Agostinelli, C., Paterson, J.C., Gupta, R., Righi, S., Sandri, F., et al. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. Histopathology 61 (2012), 33–46.
10. [10] Ma, S., Guan, X.Y., Beh, P.S., Wong, K.Y., Chan, Y.P., Yuen, H.F., Vielkind, J., Chan, K.W., The significance of LMO2 expression in the progression of prostate cancer. J. Pathol. 211 (2007), 278–285.
11. [11] Schulman, B.A., Harper, J.W., Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 10 (2009), 319–331.
12. [12] Fan, W., Cai, W., Parimoo, S., Schwarz, D.C., Lennon, G.G., Weissman, S.M., Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 44 (1996), 97–103.
13. [13] Bates, E.E., Ravel, O., Dieu, M.C., Ho, S., Guret, C., Bridon, J.M., Ait-Yahia, S., et al. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur. J. Immunol. 27 (1997), 2471–2477.
14. [14] Raasi, S., Schmidtke, G., de Giuli, R., Groettrup, M., A ubiquitin-like protein which is synergistically inducible by interferon-γ and tumor necrosis factor-α. Eur. J. Immunol. 29 (1999), 4030–4036.
15. [15] Hipp, M.S., Kalveram, B., Raasi, S., Groettrup, M., Schmidtke, G., FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell Biol. 25 (2005), 3483–3491.
16. [16] Jin, J., Li, X., Gygi, S.P., Harper, J.W., Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 447 (2007), 1135–1138.
17. [17] Chiu, Y.H., Sun, Q., Chen, Z.J., E1-L2 activates both ubiquitin and FAT10. Mol. Cell 27 (2007), 1014–1023.
18. [18] Raasi, S., Schmidtke, G., Groettrup, M., The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 276 (2001), 35334–35343.
19. [19] Gong, P., Canaan, A., Wang, B., Leventhal, J., Snyder, A., Nair, V., Cohen, C.D., Kretzler, M., D'Agati, V., Weissman, S., Ross, M.J., The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J. Am. Soc. Nephrol. 21 (2010), 316–326.
20. [20] Zhang, D.W., Jeang, K.T., Lee, C.G., p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 25 (2006), 2318–2327.
21. [21] Yuan, R., Wang, K., Hu, J., Yan, C., Li, M., Yu, X., Liu, X., Lei, J., Guo, W., Wu, L., Hong, K., Shao, J., Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying beta-catenin degradation. Cancer Res. 74 (2014), 5287–5300.
22. [22] Hochstrasser, M., Origin and function of ubiquitin-like proteins. Nature 458 (2009), 422–429.
23. [23] Aichem, A., Kalveram, B., Spinnenhirn, V., Kluge, K., Catone, N., Johansen, T., Groettrup, M., The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation. J. Cell Sci. 125 (2012), 4576–4585.
24. [24] Groettrup, M., Pelzer, C., Schmidtke, G., Hofmann, K., Activating the ubiquitin family: UBA6 challenges the field. Trends Biochem. Sci. 33 (2008), 230–237.
25. [25] Gavin, J.M., Chen, J.J., Liao, H., Rollins, N., Yang, X., Xu, Q., et al. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6. J. Biol. Chem. 287 (2012), 15512–15522.
26. [26] Guo, H., Tan, P., Relationship between FAT10 expression and biological behaviors in infitrating ductal carcinoma of breast. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 39 (2014), 1125–1130.
27. [27] Liu, L., Dong, Z., Liang, J., Cao, C., Sun, J., Ding, Y., Wu, D., As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway. Oncogene 33 (2014), 909–920.